V E Steele
Overview
Explore the profile of V E Steele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
1644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balansky R, Ganchev G, Iltcheva M, Steele V, DE Flora S
Curr Cancer Drug Targets
. 2011 Dec;
12(2):164-9.
PMID: 22165969
Birth is characterized by an intense oxidative stress resulting in nucleotide alterations and gene overexpression in mouse lung. We showed that cigarette smoke (CS) is carcinogenic when exposure starts soon...
2.
Morgan D, Humphreys J, Bilotta J, Nixon J, Hatch G, Steele V
Toxicol In Vitro
. 2010 Aug;
4(2):123-7.
PMID: 20702272
Differences in the sensitivity of human and Fischer 344 rat tissues to cadmium sulphate (CdSO(4)) toxicity were investigated in an in vitro model using human and rat nasal turbinate epithelial...
3.
Christov K, Moon R, Lantvit D, Boone C, Kelloff G, Steele V, et al.
Eur J Cancer
. 2004 Jun;
40(9):1404-11.
PMID: 15177500
In most prostate chemoprevention studies conducted with animal models, the incidence and multiplicity of tumours have been used as endpoints for efficacy. However, the latency of tumours is usually over...
4.
Estensen R, Jordan M, Wiedmann T, Galbraith A, Steele V, WATTENBERG L
Carcinogenesis
. 2003 Oct;
25(2):197-201.
PMID: 14578161
The effects of aerosol budesonide and dietary myo-inositol on progression of benzo[alpha]pyrene (B[alpha]P) induced carcinogenesis were studied in A/J mouse lung. First, we determined when to intervene in the carcinogenesis...
5.
Christov K, Shilkaitis A, Kim E, Steele V, Lubet R
Eur J Cancer
. 2003 Jan;
39(2):230-9.
PMID: 12509956
Terminal replicative senescence (TRS) is a physiological process associated with terminal differentiation, shortening of the telomere, and lack of proliferative activity. Immortalised and tumour cells have lost their differentiation potential...
6.
Sharma S, Ghoddoussi M, Gao P, Kelloff G, Steele V, Kopelovich L
Anticancer Res
. 2002 Mar;
21(6A):3829-37.
PMID: 11911254
One of the approaches in chemoprevention to prevent or delay the progression of precancerous lesions, is to apply chemopreventive agents that can potentially block angiogenesis. A quantitative in vivo angiogenesis...
7.
DAmbrosio S, Wani G, Casto B, Milo G, Kelloff G, Steele V
Anticancer Res
. 2002 Feb;
21(5):3229-35.
PMID: 11848477
Background: Aberrant expression of Ki67, p53 and RARbeta are characteristic of many tumor types including those of the oral cavity. Chemopreventive agents may act by modulating their expression to more...
8.
Elmore E, Luc T, Steele V, Redpath J
In Vitr Mol Toxicol
. 2002 Feb;
14(3):191-207.
PMID: 11846992
Comparative toxicity was determined for twenty potential chemopreventive agents in the Human Epithelial Cell Cytotoxicity (HECC) Assay using epithelial cell cultures from eight different tissues including: skin, kidney, breast, bronchus,...
9.
Knott K, McGinley J, Lubet R, Steele V, Thompson H
Breast Cancer Res Treat
. 2002 Jan;
70(3):171-83.
PMID: 11804181
Vorozole, a nonsteroidal aromatase inhibitor, impedes the post-initiation stage of chemically induced mammary carcinogenesis. While various aspects of vorozole's effects on mammary carcinoma development have been investigated, little attention has...
10.
Mehta R, Bhat K, HAWTHORNE M, Kopelovich L, Mehta R, Christov K, et al.
J Natl Cancer Inst
. 2001 Jul;
93(14):1103-6.
PMID: 11459872
No abstract available.